Think of the biggest medical challenges of our time and you’ll find researchers tackling them at the FSU-headquartered National High Magnetic Field Laboratory. The MagLab harnesses some of the most powerful magnets on Earth to unlock the secrets of human biology, peering deeper into molecular structures than ever before. Cutting-edge research on cancer, migraines, stroke, Alzheimer’s disease and many other conditions is helping pave the way for next-generation treatments, faster diagnoses, and life-changing cures. As part of FSU Health, the MagLab brings together world-class scientists and clinical partners to improve the future of medicine in Florida.

Here are seven ways the MagLab is pushing the frontiers of medicine and advancing human health.

 Targeting a Key Cancer Driver

MagLab researchers have uncovered an important clue about how the KRAS gene drives cancer. KRAS is a gene that helps control when cells grow, divide and die. When KRAS mutates, those signals can get stuck in the “on” position, causing cells to multiply uncontrollably. Mutated KRAS is strongly associated with several major cancers, including pancreatic cancer, colorectal cancer and non-small cell lung cancer. Using Ion Cyclotron Resonance mass spectrometry, researchers mapped the structures of intact KRAS proteins in colon cancer tumors. In the process, they discovered a previously unknown, shortened version of the KRAS protein that moves differently inside cells and sends growth signals to the cell’s DNA. The finding gives scientists new insight into how KRAS-related cancers develop and could help guide the design of more precise and effective cancer therapies.

Promoting Stroke Recovery

Scientists using the world’s strongest MRI have identified a promising approach for stroke treatment using human stem cells. They reconfigured the cells to promote healing and growth, so the stem cells would survive the hostile environment of a stroke lesion. Tested in pre-clinical models, these aggregated stem cells improved survival, reduced brain lesion sizes and stimulated noticeable motor function recovery, offering a promising strategy to boost the effectiveness of future stroke therapies.

Seeking New Drugs to Fight Antibiotic Resistant Bacteria

An interdisciplinary team of researchers has launched an ambitious effort to combat the growing threat of drug-resistant bacteria. The team plans to screen a billion soil microbes from around the world in search of natural compounds that could become new antibiotics. The project will leverage the MagLab’s Ion Cyclotron Resonance mass spectrometers to analyze and identify these novel bioactive molecules for drug development. Drug-resistant bacterial infections are one of the world’s leading causes of death, with cases expected to rise dramatically in the next 25 years.

Characterizing Cartilage to Improve Treatments for Joint Disease

Using advanced, solid-state Nuclear Magnetic Resonance and a technique called Dynamic Nuclear Polarization, researchers successfully observed the microscopic interactions of sugars and proteins in cartilage for the first time. They discovered that the sugars and proteins bind directly to one another at an atomic level, forming tiny “bridges” that hold the structure together. This breakthrough could lead to better treatments for joint diseases like osteoarthritis and improve the development of synthetic cartilage materials.

Mapping the Protein that Powers Tuberculosis

Harnessing the National MagLab’s high-powered Electron Paramagnetic Resonance spectrometer, chemists mapped a unique protein linked to deadly, virulent strains of tuberculosis. Unlike similar proteins, this rule-breaking variant has an unoccupied atomic site. Researchers believe this open site acts like a plug-in for molecules that help the bacteria function. It’s also believed the protein may help build TB’s thick, waxy cell walls, which make it less susceptible to treatment. The finding represents a critical first step toward understanding how the protein may help tuberculosis bacteria survive and could potentially lead to the design and development of new TB treatments.

Pinpointing the Precursors of Migraines

MagLab researchers have discovered a link between migraines and sodium distribution in the brain. The team scanned rats and found a spike in sodium levels within the brainstem before any migraine symptoms appeared. This new finding helps pinpoint exactly where migraine symptoms may start. Moving forward, the scientists plan to study whether existing treatments impact this sodium buildup, paving the way for more effective future therapies for millions of migraine sufferers.

Delving into a Deadly Fungus

Using a powerful Nuclear Magnetic Resonance technique, MagLab scientists mapped the complex cell wall of Cryptococcus, a drug-resistant fungus that kills tens of thousands of people globally every year. They discovered that five distinct large sugar molecules act as an internal scaffold to protect the fungal cell. This sturdy framework explains why the fungus survives so well inside the human body and resists many modern antifungal drugs. By learning how this molecular shield is built, the research opens new opportunities to design more effective targeted antifungal therapies.

The post Seven ways the MagLab is advancing healthcare appeared first on Florida State University News.

The post Sky Therapeutics, Florida State University announce first FDA Breakthrough Device designation for ADHD treatment appeared first on Florida State University News.

The post As Florida launches newborn genetic screening program, FSU institute leads statewide effort appeared first on Florida State University News.

A Florida State University research team has received a $350,000 grant from the Humana Foundation to develop and test an artificial intelligence-powered system that helps older adults build social connections through volunteering and community engagement.

The two-year project, “ALCOVE: A Personalized AI Concierge to Promote Community Engagement and Social Connectedness Among Older Adults,” will create a digital platform tailored to the needs, preferences and lifestyles of older adults across North Florida.

Led by FSU School of Information Professor and Institute for Successful Longevity Director Zhe He, the interdisciplinary team includes co-principal investigators Mia Liza A. Lustria and Dawn Carr, along with collaborators from multiple FSU departments and partner institutions.

“Social isolation is one of the most pressing public health crises, yet it is often an overlooked challenge facing older adults, and this grant from the Humana Foundation gives us the opportunity to do something meaningful about it,” He said. “ALCOVE harnesses the power of AI to help older adults find meaningful volunteer and social activities in their community — in a way that feels personal and supportive. It supports people in taking meaningful steps to reconnect with their communities and improve their overall well-being. We are deeply grateful to the Humana Foundation and look forward to making a real difference in the lives of older adults in North Florida.”

The ALCOVE system will function as a personalized “digital social concierge,” guiding users through a simple conversational process to learn about their interests, mobility, transportation options and social preferences. The platform will then match participants with vetted volunteer and community opportunities and provide ongoing reminders, encouragement and follow-up support to help them stay engaged.

The project addresses a growing public health concern. Research has linked chronic loneliness among older adults to increased risks of cognitive decline, heart disease, depression and premature death, as well as billions of dollars in annual health care costs. ALCOVE aims to connect older adults to community, purpose and opportunity.

“Finding opportunities is only part of the solution. People are much more likely to stay engaged when opportunities reflect who they are and fit the realities of their daily lives,” Lustria said. “AI makes that level of personalization possible by learning about each person’s interests, motivations, abilities, transportation options, and other real-world circumstances, allowing ALCOVE to deliver tailored recommendations and ongoing support that simply wouldn’t be feasible at this scale. Ultimately, our goal is to make meaningful community engagement more accessible, helping older adults find purpose, build relationships, and strengthen their connections with the communities around them.”

Carr, director of FSU’s Claude Pepper Center, noted the importance of the specific focus of this project on volunteering.

“Volunteering is a particularly novel and important health behavior to focus on with older adults at risk of experiencing social isolation and loneliness because it is among the most well-established activities for promoting meaningful social connections,” she said. “Not only does volunteering help people feel more connected in the community and with others, it’s also as effective as other health behaviors like exercising and eating well, showing that people who regularly volunteer experience reduced physiological aging over time.”

The project reflects FSU’s leadership in community-engaged and innovative aging research. ALCOVE builds on more than seven years of collaborative research by the team, including NIH-funded efforts to develop AI tools that support healthy aging and long-term engagement among older adults.

The Humana Foundation grant supports the development of the AI system, community-based research and evaluation of outcomes related to social engagement, loneliness and emotional well-being.

Through focus groups and co-design workshops, researchers will work with older adults in North Florida to identify challenges to social participation and shape the platform’s development. The team will then test the system in a two-year pilot study with approximately 50 participants.

Ultimately, the research team aims to use findings from the ALCOVE pilot to pursue additional federal funding and expand the platform to serve older adults nationwide.

The project includes collaborators from Weill Cornell Medicine and Arizona State University, as well as community partners such as the Tallahassee Senior Center, which will help connect researchers with local participants and organizations.

The post FSU researchers awarded $350K Humana Foundation grant to fight senior isolation with AI concierge technology appeared first on Florida State University News.

Florida State University, through FSU Health, has awarded $250,000 to the five inaugural recipients of its Clinical Catalyst Grant Program, an initiative that brings together FSU researchers and local clinical providers to address healthcare challenges through collaborative projects. 

“Clinical Catalyst creates an exciting opportunity for our research teams to join forces with local clinical providers and accelerate progress on some of the most urgent issues affecting patient care in our community,” said Vice President for Research Stacey S. Patterson.  

FSU launched Clinical Catalyst to give clinicians an opportunity to share ideas for addressing healthcare needs identified through their daily work. The program also supports the broader goals of FSU Health by bringing additional resources and opportunities to healthcare in the region. 

The 2025-2026 Clinical Catalyst awardees are: 

• Accessible and Engaging Non-Pharmacologic Management of Chronic Pain Combining Music Therapy and Brain Stimulation: Kevin Johnson from the FSU College of Medicine and his team are partnering with Dr. Gilbert Chandler from Tallahassee Orthopedic Clinic to explore a promising, non-drug approach to chronic musculoskeletal pain by combining music therapy with Transcranial Magnetic Stimulation. 

• Building a New Care Pathway: ICAN-Guided Nutrition Support for Aging Adults in Clinical Settings: Julia Sheffler at the FSU College of Medicine and a multidisciplinary team of nutrition and exercise experts are collaborating with Dr. Cielo Rose from Capital Health Plan’s Nancy Van Vessem Center for Healthy Aging to build a structured nutrition and lifestyle program designed to better support older adults in clinical settings. 

• Feasibility, Acceptability, and Preliminary Efficacy of Vagus Nerve Stimulation for Stroke Aphasia: Sladjana Lukic from the FSU School of Communication Science and Disorders, in partnership with Dr. Narlin Beaty at Tallahassee Neurological Clinic, is exploring an innovative approach that could help stroke survivors regain language abilities by reactivating critical neural networks. 

• Redesigning Post-Mastectomy Bras: Investigating Design Innovations to Reduce Seroma and Hematoma Formation and Enhance Patient Satisfaction: Jessica Ridgway Clayton from the FSU Jim Moran College of Entrepreneurship is working with Dr. Shlermine Everidge from TMH Physician Partners, to develop improved bras for mastectomy patients to support recovery, improve comfort and enhance patient satisfaction. 

• Increasing the Uptake of Advanced Care Directives in Hospital and Clinical Settings: Miles Taylor from the FSU Pepper Institute on Aging and Public Policy, in collaboration with Dr. R. Kelley Myers from the Tallahassee Memorial Family Medicine Residency Program, aims to make end-of-life planning easier and more accessible for patients and families while helping reduce unnecessary medical treatments and costs. 

“These projects reflect the strength of interdisciplinary collaboration at FSU and our shared commitment to delivering innovative ideas that can make a meaningful difference in clinical practice and patient outcomes,” Patterson said.  

### 

FSU Health brings together researchers, clinicians and local clinical partners under one umbrella to transform health and healthcare in Florida. To learn more about FSU Health, visit  fsuhealth.fsu.edu. 

The post FSU awards inaugural Clinical Catalyst grants to advance bold healthcare innovation appeared first on Florida State University News.

Conference brings together researchers, clinicians, industry leaders and families to discuss advances in genomic screening and gene therapy

For families affected by rare diseases, unexplained developmental delays or medical symptoms often mark the beginning of a “diagnostic odyssey,” a frustrating search for answers and treatment options.

The longer the search continues, the greater the emotional toll on families. Without a diagnosis, effective treatment may be delayed. Millions of families worldwide face this challenge each year.

The Florida Institute for Pediatric Rare Disease (Florida IPRD) at the Florida State University College of Medicine is working to shorten that journey.

Through a newborn whole-genome sequencing pilot program, family counseling, care management, rare disease research initiatives and professional training, FSU faculty and scientists are helping families better care for their loved ones with a rare disease.

With support from the state legislature, Florida IPRD is helping to expand access to genomic medicine and accelerate research into rare diseases to transform lives. The institute is partnering with the A.J. Anderson Foundation on its shared mission to improve pediatric rare disease healthcare.

Transforming personal tragedy into a movement to help Florida families

Rep. Adam Anderson (R-Palm Harbor) and his wife, Brianne, started the A.J. Anderson Foundation in 2018 after their son Andrew was diagnosed with Tay-Sachs disease, a rare genetic disorder that destroys nerve cells in the brain and spinal cord. Their own diagnostic odyssey followed as they sought care for their son. The experience prompted them to look for a way to support other families seeking rare disease treatment.

The foundation’s goals are to advocate for improved research and treatment to put an end to pediatric rare diseases and to increase access to genetic testing.

“The partnership between the A.J. Anderson Foundation and the Florida Institute for Pediatric Rare Diseases demonstrates what can be accomplished when advocacy, science, medicine, industry and public policy come together to accelerate diagnosis, expand treatment opportunities, and improve outcomes for children with rare diseases,” said Pradeep Bhide, director of Florida IPRD. “Representative Anderson and Brianne Anderson have been extraordinary champions for children with rare diseases, and their leadership has helped create programs such as ours that are positioning Florida as a national leader in genomic medicine and early diagnosis.”

Rare Disease Conference: Bringing together research and industry leaders

On Wednesday, the A.J. Anderson Foundation and Florida IPRD cohosted a rare disease conference in Pinellas County, bringing together researchers, healthcare professionals, industry partners and families to learn about ongoing work and provide a look into the future of treatment.

Dr. David Bick, the principal clinician for the Newborn Genomes Programme at Genomics England, delivered the keynote address. Attendees also heard from two panels, one focused on genomic newborn screening and the other focused on advances in gene therapy. Panelists from GeneDx, Nest Genomics, Alexion Pharmaceuticals and Amazon Web Services shared their insight in the first session. Panelists from UMass Chan Medical School, Florida IPRD and the University of Florida spoke during the second session.

Together, the panels represented two major, complementary goals: Diagnosing children with rare disease at birth and offering them an opportunity for early intervention and rapid treatment.

“The promise that these gene and cell therapies offer is that if you can detect a condition at birth, before symptoms occur, you can prevent those symptoms from ever showing themselves, and that child can live a perfectly healthy life,” Anderson said.

The Sunshine Genetics Program

Genomics medicine in Florida received a major boost last year with the passage of the Sunshine Genetics Act. With the support of the state legislature and Gov. Ron DeSantis, the act established the Florida Institute for Pediatric Rare Diseases and provided additional funding for research and a genetic screening pilot program.

For the Floridians who now have the opportunity to screen their children for a rare disease and for the millions more people who can be helped through research breakthroughs, the work is urgent and crucial.

“Rare diseases test our healthcare systems, our scientific capabilities and our collective compassion. At the same time, they inspire determination, collaboration and hope,” said Dr. Alma Littles, dean of the FSU College of Medicine. “At Florida State University, we are proud to support the Florida Institute for Pediatric Rare Diseases and the Sunshine Genetics initiative as part of our broader commitment to expanding precision medicine, expanding access to care, and bringing together clinicians, scientists, educators, policymakers, industry leaders and patient advocates around a shared mission.”

Visit the Florida IPRD website for more information about the institute. Visit the A.J. Anderson Foundation website to learn more about the organization’s mission.

The post Institute for Pediatric Rare Diseases at FSU, A.J. Anderson Foundation expand access to genetic screening and rare disease care appeared first on Florida State University News.

Florida State University’s College of Communication and Information, through its School of Communication Science and Disorders, will launch the FSU Health Mobile Speech and Hearing Clinic later this summer, expanding healthcare services that the university has provided to Floridians since the 1950s.

The mobile clinic will bring screenings, evaluations and therapy to underserved communities throughout North Florida and the Panhandle, while also providing hands-on clinical training for FSU students.

Led by Director Becky Greenhill, a speech-language pathologist and clinical instructor, the fully accessible clinic builds on the longstanding work of FSU’s Speech and Hearing Clinic, which serves children and adults with communication disorders, cognitive challenges and hearing conditions.

Greenhill discussed the growing need for speech and hearing services, the role the mobile clinic will play in rural communities and how the effort reflects Florida State’s broader healthcare mission through FSU Health.

The post FSU Health expands speech and hearing services with new mobile clinic appeared first on Florida State University News.

A team of researchers from Florida State University and the National High Magnetic Field Laboratory is looking to nature to find microbes that can be used to create new antibiotics to treat the growing threat of drug-resistant bacteria.

Infection from so-called “super bugs” is a leading cause of death globally. Drug resistant bacteria contribute to nearly five million deaths every year, according to the World Health Organization. As more pathogens develop resistance, that number is expected to jump nearly 70% in the next 25 years.

The team of FSU and MagLab researchers will screen soil microbes from around the world to hunt for sources of new antibacterial drugs. The Novo Nordisk Foundation is funding the project as part of an international drug discovery initiative.

“People have been searching for new antibiotics for many years, but it is becoming increasingly difficult to discover novel compounds. Our goal is to revolutionize the drug discovery pipeline,” said Xiangpeng Li, an assistant professor in the FSU Department of Chemistry and Biochemistry. “If we don’t do anything, antibiotic resistance will be a huge problem for the human race.”

Buried treasure: Potential medical marvels in the soil

Molecules made by microbes have long been used to treat bacterial infections. The first antibiotic, penicillin, was developed from mold nearly 100 years ago. Common antibiotics like streptomycin are produced by bacteria.

The researchers will test soil samples supplied by Rob Spencer, a biogeochemist and professor in the Department of Earth, Ocean, and Atmospheric Science. He studies the carbon cycle, and particularly the rapidly changing environments of the Arctic and tropics.

“It’s common to think about soils as just dirt, but they are essential for our nutrient, carbon and water cycles, and microbes in soils hold huge potential for discovery of new drugs,” Spencer said.

His samples from extreme environments like the polar regions hold particular promise because they have not been extensively examined.

“Those samples might contain very novel microbes,” Li said. “They have been frozen for maybe tens to hundreds of thousands of years. We are more likely to find new things.”

How it works

To find sources for potential new antibacterial drugs, the team has the ambitious goal of screening a billion microbes.

Li specializes in droplet microfluidics, manipulating tiny drops of fluid about the width of a human hair through troughs etched on a silicone disc to rapidly conduct chemical screening. His microfluidics system will quickly process tens of thousands of droplets at a time.

“Typically, when we search for new compounds from nature, it’s a rather arduous process working with individually isolated microbes, but with the speed of microfluidics and the analytical power of the Ion Cyclotron Resonance Facility, we can sample all of the microbes from a variety of environments all at once. It’s a very exciting collaboration,” said Edward Kalkreuter, an assistant professor in the Department of Chemistry and Biochemistry.

Inside the droplets, soil microbial cells will be combined with a common antibiotic-resistant bacterium called Klebsiella pneumoniae and a fluorescent color-coded tag to allow for rapid sorting.

Then the MagLab’s Ion Cyclotron Resonance Facility, or ICR, will identify bioactive molecules from the soil microbes.

“You might have a soil sample and it kills the Klebsiella, but you don’t know what those molecules are. So that’s where we come in,” said ICR Director Kicki Håkansson.

The lab’s powerful ICR mass spectrometers will analyze the droplets that show antimicrobial activity to determine which molecules are responsible for the antibacterial properties. The precision analysis will also be crucial for making sure the discovery is indeed new.

“We’re looking for signals that have not been discovered before. We don’t want to rediscover penicillin,” Li said. “To do that, we annotate the molecular composition of each signal and compare it against databases of known compounds.”

Taking on that data analysis challenge will be the team’s fifth member, Ryan Rodgers, a researcher at the ICR.

International collaboration

The researchers will also share data and ideas with 21 other research groups around the world as part of an international drug discovery consortium with additional funding provided by the Gates Foundation and the Wellcome Trust. This coordinated investment and collaborative effort will accelerate the search for new medications that are crucial to addressing this growing crisis.

“This new approach allows us to look very thoroughly at compounds that haven’t been looked at,” Håkansson said. “And if we find something, this could be transformative, which is what’s really exciting.”

The post Florida State University, National MagLab investigate soil microbes from around the world for new antibacterial drugs appeared first on Florida State University News.

Bracketed by the musical works of Sir Edward Elgar’s “Pomp and Circumstance,” the 121-member Florida State University College of Medicine Class of 2026 marched into Ruby Diamond Concert Hall Saturday as students and marched out as doctors.

Joining them in the recessional line were seven newly minted Master of Science in Biomedical Sciences – Bridge to Clinical Medicine graduates, who in 10 days will begin their own march to becoming doctors as members of the M.D. Class of 2030.

Dr. Anthony Speights, senior associate dean for medical education and academic affairs, broke from the ceremonial as he donned a wireless microphone and delivered the commencement address facing the class.

“On to the life lesson of the day.  Your last, and hopefully best, lesson from me,” Speights said, his back to the audience and eyes locked on the students before him on stage.

Speights’ address ranged widely from playful to poignant; focused on his observations of how students had changed since he and his Generation X peers “believe we were just built different” than the students he addressed.

For illustration he referred to his generation as latchkey kids, the MTV generation that never used seatbelts and the first generation with cell phones; as residents who worked 100-hour weeks without time restrictions, slept in the hospital call room and, in many instances became physicians who were absent from home, grumpy, placed patients and career before everything, and burned out.

“Now that I’ve spent so much time over the years telling you how different your generation is than mine as if it’s a bad thing, let me tell you why your generation is different than mine, in all the ways I admire.

“You’ve learned to support each other in ways our generation never did.  You’ve come to understand the need for balance in work and life.

“You’ve heard me say many times, often in what sounded like a critical way, that your generation doesn’t want to work as hard as the ones before you. But in all honesty, after all these years I can let you in on a little secret. That wasn’t criticism. It was jealousy.”

Speights praised the class — and its generation — for how it has found ways to be efficient and work hard, but find time to “smell the roses, watch some Netflix and hang out.” How it had taught his generation of physicians the importance of mental self-care.

And he reminded the class of a message delivered to them by the late Dr. Daniel Van Derme on their first day as medical students.

”Dan said something like this: Each of us is filled with a reservoir of compassion and caring.  It’s like a river, flowing from you to your patients.  Guard against becoming jaded, because it will dam that river up, but also keep in mind that if your reservoir is constantly flowing, it has to be refilled or it will run dry.

“Find and do things that refill that reservoir of compassion and caring. Caring is integral. Patients don’t care how much you know, until they know how much you care.”

There is no shortage of physicians from the class who heeded that advice; many of whom were honored on the eve of commencement at the Class of 2026 Presentation of Awards ceremony.

Ben Linkus, who completed his final two years at the Pensacola Regional Campus near his hometown of Gulf Breeze, received the Mission Award. Linkus is headed to Newark, Delaware, for a general surgery residency; a departure from the family medicine route he initially envisioned for himself. His third-year rotation through the Marinna Rural Program at the 100-bed Jackson Hospital, changed his trajectory, thanks to the influence of doctors Vechai Arunakul and John Brunner.

“I fell in love with rural healthcare and what the general surgeon can do in those types of communities,” Linkus said. “[Arunakal and Brunner] were huge role models for me, being able to see how they impacted the community. Eventually, the plan is to come back to the Panhandle and be the rural general surgeon in a community along I-10.

Befitting of her strong faith, Katelyn Cornelius was selected to deliver the invocation Saturday.

“My faith has always been a big part of my life,” said Cornelius, who completed her clinical education at the Orlando Regional Campus, near her hometown of Winter Park. “Before I stated medical school, I got to work at a clinic for patients without insurance that’s faith-based in Orlando. I really saw how these people’s desire to serve was so driven by their faith. And I worked with a pediatrician who used to talk about how, you know, we’re called to be loving in anything that we do.

Cornelius carried that mindset throughout her time at the College of Medicine and others noticed. At Friday nights’ awards ceremony, the Alpha Omega Alpha and Gold Humanism Honor Society inductee was recognized as the Orlando Regional Campus Dean’s Award winner and one of eight American Medical Women’s Association’s Glasgow-Rubin Citation recipients for ranking in the top 10% of her class and demonstrating leadership, service and advocacy.

Dr. Alma Littles, dean of the College of Medicine, presented Cornelius the J. Ocie Harris Outstanding Student Award, which recognizes the student who has shown the best all-around promise of becoming a physician of the highest caliber.

“People ask me, ‘Why are you like this? Why are you so nice and kind and focused? Why do you know this information?” she explained. “For me, it is loving and caring, and that feels like my mission and my ministry to others; to learn this information well, to care for people well, to help them feel seen and heard and loved at the end of the day.”

The post FSU College of Medicine graduates 121 new doctors appeared first on Florida State University News.

Routine high-tide flooding in coastal communities could lead to thousands of deaths among older adults by the end of the century, according to a new study co-authored by Florida State University researcher Mathew Hauer.

Published in The Lancet Planetary Health, the study projects that without significant adaptation, premature deaths among adults aged 65 and older linked to high-tide flooding could increase 43-fold by 2100.

Unlike storm surges from major hurricanes, high-tide flooding happens regularly and is often viewed as a nuisance rather than a danger. But researchers found even shallow flooding on roads can delay emergency medical care for older adults during time-sensitive emergencies such as cardiac arrest.

“When we think about climate change threatening people’s lives, we picture hurricanes and heat waves,” Hauer said. “What we found is that the routine, ankle-deep flooding people have learned to live with is on track to kill more older adults than storm surge does in these same coastal areas. It’s a quiet, cumulative form of climate mortality, and until now nobody had put a national number on it.”

The research team, which included Hauer from the FSU College of Social Sciences and Public Policy’s Department of Sociology and Center for Demography and Population Health, found that flooding creates significant traffic disruptions that obstruct emergency medical access. This is particularly dangerous for time-sensitive conditions where every minute of delay significantly reduces survival rates.

Researchers identified three major findings:

• A growing crisis: By 2100, the model projects nearly 10,000 additional deaths annually among older adults in coastal U.S. regions.
• Economic impact: The monetized damages associated with these premature deaths could reach $1.1 trillion by the end of the century.
• The 8-minute threshold: Seniors living in areas with more than an 8.85-minute drive to the nearest hospital are especially vulnerable to these flood-induced delays.

The findings are a wake-up call for the Sunshine State, which stands at the epicenter of the issue.

The study identified Florida as the nation’s most vulnerable state because of its large older population and extensive low-lying coastline.

“Simple things like raising roadways, better sited-hospitals, and other changes could make a significant impact on reducing this anticipated mortality. An ounce of prevention today is worth a pound of cure tomorrow.”

– Mathew Hauer, FSU associate professor and study co-author

By 2060, Florida could account for 24% to 38% of all high-tide flooding deaths in the coastal contiguous U.S., with an estimated 360 to 1,590 annual fatalities.

“Florida has twin threats of an older population and a large, low-lying coastal zone,” Hauer said. “So, the demography, the geography and climate change all combine to account for a large percentage of these anticipated deaths.”

Researchers said the projected death toll could be significantly reduced through infrastructure improvements and planning. Implementing protective measures, such as elevating roads or building new healthcare facilities in accessible locations, could reduce premature deaths by 57%.

The researchers recommend three critical steps for coastal communities:

• Protect road networks that are essential for emergency medical access.
• Increase accessibility by building more critical care facilities in at-risk coastal areas.
• Manage the retreat of vulnerable populations to areas with better infrastructure and healthcare access.

The study concluded that the economic costs associated with these deaths exceed many other climate-related impacts, making healthcare infrastructure a priority for policymakers.

“The deaths show up when an ambulance can’t get through and the adaptive infrastructure to prevent these are things we already know how to do,” Hauer said. “Simple things like raising roadways, better sited-hospitals, and other changes could make a significant impact on reducing this anticipated mortality. An ounce of prevention today is worth a pound of cure tomorrow.”

The study was funded by the U.S. Environmental Protection Agency and included collaborators from Arizona State University, Industrial Economics and the International Food Policy Research Institute.

The post FSU study warns routine coastal flooding could become deadly for older adults appeared first on Florida State University News.

Florida State University students from the College of Communication and Information helped restore hearing for hundreds of patients during a service-learning trip to Guatemala last semester. 

Selena Snowden, teaching faculty III and director of Audiology Services in the School of Communication Science and Disorders, led a group to Sololá, Guatemala, where students performed more than 100 ear cleanings, fitted 276 hearing devices and saw more than 200 patients for appointments during four days of clinics. 

Known as the “Help Guatemala Hear” service trip, Snowden has led groups of students and professionals on similar service trips since 2015, pausing only during the pandemic. The program aims to provide the “gift of sound” to children, adults and indigenous people in the region.  

“I love to witness how the students grow each year clinically, personally, and in humility over the course of experience,” Snowden said.  

A record number of students participated in the trip: 14 undergraduate students and three graduate students from FSU, along with one undergraduate student studying communication sciences and disorders at Valdosta State University.  

The post FSU audiology students provide hearing care to hundreds during Guatemala service trip appeared first on Florida State University News.

The Florida State University College of Nursing has launched its first micro-credential series that integrates artificial intelligence and nursing care.

The program, Nursing Essentials of Responsible AI, was developed in partnership with the Coalition for Health AI (CHAI) and provides nurses with a comprehensive framework for the ethical and effective use of artificial intelligence in clinical practice. As artificial intelligence rapidly reshapes healthcare delivery, there is an urgent need to prepare the nursing workforce to engage with these technologies safely and effectively.

“As AI continues to transform the healthcare landscape, we are taking a proactive role in ensuring that the nursing workforce is prepared to lead this digital evolution,” said Jing Wang, dean of the FSU College of Nursing. “Nurses are at the heart of patient care, and as AI becomes an integral part of the healthcare team, they must have the tools to ensure its use is safe, ethical and human-centered. This micro-credential program further secures our commitment to advancing nursing innovation and creating top-tier nurses who are prepared for the future.”

The series includes seven micro-credentials that cover key elements of AI, from foundational principles and data privacy to practical applications of AI tools across various nursing workflows. Designed for flexibility, the courses are self-paced and tailored to meet the needs of working healthcare professionals.

The program was developed in strategic collaboration with CHAI, a leading nonprofit coalition dedicated to establishing consensus-driven best practices for health AI. This first-of-its-kind partnership reflects the academic institution’s leadership in program design, leveraging CHAI’s expertise to inform the development of AI-focused education specifically for nurses.

“CHAI’s mission is to advance the responsible use of health AI through consensus-driven guidelines,” said Dr. Brian Anderson, CEO of CHAI. “Partnering with the FSU College of Nursing is a natural extension of that work. By equipping nurses, the frontline of care delivery, with the skills to evaluate and use AI responsibly, we help ensure technology serves patients first. We are proud to support FSU in setting a new standard for nursing education.”

The Nursing Essentials of Responsible AI series is part of the FSU College of Nursing’s broader commitment to advancing innovation in nursing. In 2024, the college launched the nation’s first MSN in AI Applications in Healthcare and the Nursing and Artificial Intelligence Innovation Consortium.

To learn more about the micro-credential program or to begin taking courses, visit nursing.fsu.edu/responsibleai.

###

ABOUT CHAI

CHAI was started by clinicians. The coalition’s mission is to build the broadest possible consensus across the health ecosystem to help ensure health AI is trusted, secure and safe. The CHAI membership is open and rapidly expanding. Today, we consist of more than 3,000 members, including health systems, patient advocacy groups, academia, and a wide range of industry start-ups and incumbents. CHAI is committed to convening and dialogue to achieve consensus. There are no limits to who can join and participate. Learn more about a CHAI membership on their website.

ABOUT THE FSU COLLEGE OF NURSING

The Florida State University College of Nursing is Boldly Rising in education, research and practice, pioneering digital health and artificial intelligence in new care models, increasing enrollment to address the critical nursing shortage and attracting more than $100 million in new federal funding for innovative healthcare research.

The post FSU College of Nursing partners with CHAI to launch nation’s first micro-credential series on responsible AI for nursing appeared first on Florida State University News.